Femara 2.5 mg Film Coated Tablet *
Company:
Novartis Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 20 August 2021
File name
IPHA Femara REGPIL PF 20-0131_Jan_2021_Clean_1629451769.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 25 February 2021
File name
IPHA Femera REGPIL PF 20-0131-Clean Feb 2021 (003)_1614275366.pdf
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 25 February 2021
File name
Femara REGSPC PF 20-0131 Clean Feb 2021_1614275160.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 12 May 2020
File name
IPHA Femara2.5mgFilCoatedTablets_REGPIL_Clean Jan 2020_1589272859.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 27 November 2019
File name
IPHA_Femara2.5mgFilCoatedTablets_PIL PF19-0205 Nov 2019_Clean_1574864960.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 27 November 2019
File name
Femara REGSPC PF 19-0205 October 2019_Clean_1574863549.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 May 2019
File name
Femara 2.5mg FCT 2220784_IE_p2_LFT_X-4 RA reviewed 04.03.2019_IPHA_1557398878.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 22 March 2019
File name
Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA_1548158192.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 22 January 2019
File name
Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA_1548158192.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 24 July 2018
File name
Femara REGSPC_Clean July 2018.pdf
Reasons for updating
- Change to MA holder contact details
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 July 2018
File name
Femara REGSPC_Clean July 2018.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 September 2015
File name
PIL_8509_495.pdf
Reasons for updating
- New PIL for new product
Updated on 03 September 2015
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 23 April 2014
Reasons for updating
- Change to warnings or special precautions for use
Updated on 21 December 2012
Reasons for updating
- Change to, or new use for medicine
- Change to warnings or special precautions for use
- Change of contraindications
- Change to how the medicine works
Updated on 14 April 2009
Reasons for updating
- Change to information about pregnancy or lactation
- Change to side-effects
Updated on 05 September 2008
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 30 January 2007
Reasons for updating
- Change due to harmonisation of patient information leaflet
Updated on 29 August 2006
Reasons for updating
- Change to, or new use for medicine
Updated on 16 May 2005
Reasons for updating
- Change to, or new use for medicine
Updated on 25 August 2004
Reasons for updating
- New PIL for medicines.ie